These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


352 related items for PubMed ID: 20045300

  • 1. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?
    Walji N, Chue AL, Yap C, Rogers LJ, El-Modir A, Chan KK, Singh K, Fernando IN.
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):140-6. PubMed ID: 20045300
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 3. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M, Huang L, Liu JH, Xiong Y, Li JD, Huang X, He L, Ren YF, Wang HY.
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [Abstract] [Full Text] [Related]

  • 4. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
    Toita T, Nakamura K, Uno T, Kodaira T, Shinoda A, Ogawa K, Mitsuhashi N, Maebayashi K, Kawaguchi A, Inoue T, Teshima T.
    Jpn J Clin Oncol; 2005 Mar; 35(3):139-48. PubMed ID: 15741304
    [Abstract] [Full Text] [Related]

  • 5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 6. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 7. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 01; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 8. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T, Kato S, Ohno T, Tsujii H, Sato S, Fukuhisa K, Arai T.
    Cancer; 2005 Jan 01; 103(1):92-101. PubMed ID: 15540233
    [Abstract] [Full Text] [Related]

  • 9. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, Kim DS.
    Gynecol Oncol; 2001 Jul 01; 82(1):88-93. PubMed ID: 11426967
    [Abstract] [Full Text] [Related]

  • 10. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
    Ijaz T, Eifel PJ, Burke T, Oswald MJ.
    Gynecol Oncol; 1998 Aug 01; 70(2):241-6. PubMed ID: 9740698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):786-96. PubMed ID: 14967435
    [Abstract] [Full Text] [Related]

  • 13. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W, DO V, Hogg R, Wain G, Brand A, Bull C, Stenlake A, Gebski V.
    Aust N Z J Obstet Gynaecol; 2009 Aug 01; 49(4):419-25. PubMed ID: 19694700
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar 01; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 15. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 16. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study.
    Yamashita H, Nakagawa K, Tago M, Shiraishi K, Nakamura N, Ohtomo K, Oda K, Nakagawa S, Yasugi T, Taketani Y.
    Gynecol Oncol; 2005 Jun 01; 97(3):834-9. PubMed ID: 15894366
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A, Teti G, Barsotti C, Tana R, Fanucchi A, Orlandini C, Fabrini MG, Genazzani AR.
    Anticancer Res; 2010 Jan 01; 30(1):201-8. PubMed ID: 20150636
    [Abstract] [Full Text] [Related]

  • 18. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL, Wu LY, Li N, Li XG, Huang MN, Zhang R.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun 01; 47(6):452-7. PubMed ID: 22932113
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS, Wong EH, Tan HS, Yap SP, Chua EJ, Sethi VK, Soh LT, Low J, Tay EH, Chew SH.
    Gynecol Oncol; 2005 Apr 01; 97(1):171-7. PubMed ID: 15790454
    [Abstract] [Full Text] [Related]

  • 20. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY, Wu HG, Kim K, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2007 Jan 01; 104(1):95-9. PubMed ID: 16996117
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.